Now Reading: Nationwide shortage of two key chemotherapy drugs hits patients
-
01
Nationwide shortage of two key chemotherapy drugs hits patients
India is facing a critical shortage of cisplatin and carboplatin, two widely used chemotherapy drugs. The shortage stems from a doubling of global platinum prices, West Asia shipping disruptions, and domestic price…
The Story in Brief
India is facing a critical shortage of cisplatin and carboplatin, two widely used chemotherapy drugs. The shortage stems from a doubling of global platinum prices, West Asia shipping disruptions, and domestic price caps that made production unviable. Government hospitals in several states have stabilised supplies, but private hospitals in many areas still report interruptions. Last month the government temporarily raised ceiling rates for these drugs by 50% to restart halted manufacturing. For patients, the shortage has meant delays, interruptions, and higher costs in life-saving cancer treatment.
The Indian Opinion
The Centre's 50% price hike for cisplatin and carboplatin is a necessary but belated fix. Blaming only global platinum costs or Red Sea disruptions misses a harder truth: domestic manufacturing of essential drugs cannot rely on threadbare margins. Private hospitals still scrambling while government facilities manage better exposes a two-tier preparedness. The real test now is whether the revised ceiling actually brings production back to full scale, or whether companies find new excuses. If stocks remain tight three months from now, the price revision was never the issue.
Source: thehindu.com
This story was synthesised by AI from the source linked above.
